Haseeb Ahmad

Haseeb joined Purespring in March 2025, bringing over 25 years of experience in the life sciences industry, successfully leading organisations to create blockbuster brands, from primary care to rare diseases in both mature and growth markets.

Prior to Purespring, Haseeb served as President of Novartis Europe, where he oversaw $15 billion in revenue across 53 markets. Prior to this, he led Novartis Gene Therapies to bring first-in-class gene therapies to patients. Haseeb also held numerous global and in-country leadership roles at both Novartis and Merck & Co.

Haseeb also served as President and Chairman of the Board for the Association of the British Pharmaceutical Association and is currently Non-executive Director and Trustee at Health Data Research UK.